Mechanisms of gene regulation by vitamin D3 receptor: A network of coactivator interactions

Gene

Volumn 246, Issue 1-2, 2000, Pages 9-21

  Rachez, Christophe ^a   Freedman, Leonard P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

1,25(OH)2D3; CBP p300; DRIP; SRC 1; Transcription

Indexed keywords

CELL NUCLEUS RECEPTOR; COLECALCIFEROL; COLECALCIFEROL RECEPTOR; HISTONE; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

CHROMATIN; DRUG MECHANISM; GENE CONTROL; GENETIC TRANSCRIPTION; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; YEAST;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, CALCITRIOL; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

MAMMALIA;

EID: 0034603725     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(00)00052-4     Document Type: Review

References (111)

1. p/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 15:1995;5789-5799.
2. Baker A.R., McDonnell D.P., Hughes M., Crisp T.M., Mangelsdorf D.J., Haussler M.R., Pike J.W., Shine J., O'Malley B.W. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA. 85:1988;3249-3258.
3. Bannister A.J., Kouzarides T. The CBP co-activator is a histone acetyltransferase. Nature. 384:1996;641-643.
4. Barettino D., Vivanco Ruiz M.M., Stunnenberg H.G. Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J. 13:1994;3039-3049.
5. Baudino T.A., Kraichely D.M., Jefcoat S.C. Jr., Winchester S.K., Partridge N.C., MacDonald P.N. Isolation and characterization of a novel coactivator protein, NCoA-62, involved in vitamin D-mediated transcription. J. Biol. Chem. 273:1998;16434-16441.
6. Berghofer-Hochheimer Y., Zurek C., Wolfl S., Hemmerich P., Munder T. L7 protein is a coregulator of vitamin D receptor-retinoid X receptor-mediated transactivation. J. Cell. Biochem. 69:1998;1-12.
7. Blanco J.C., Wang I.M., Tsai S.Y., Tsai M.J., O'Malley B.W., Jurutka P.W., Haussler M.R., Ozato K. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc. Natl. Acad. Sci. USA. 92:1995;1535-1539.
8. Bourguet W., Ruff M., Chambon P., Gronemeyer H., Moras D. Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α Nature. 375:1995;377-382.
9. Boyer T.G., Martin M.E., Lees E., Ricciardi R.P., Berk A.J. Mammalian Srb/Mediator complex is targeted by adenovirus E1A protein. Nature. 399:1999;276-279.
10. Brzozowski A.M., Pike A.C., Dauter Z., Hubbard R.E., Bonn T., Engstrom O., Ohman L., Greene G.L., Gustafsson J.A., Carlquist M. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature. 389:1997;753-758.
11. Candeliere G.A., Jurutka P.W., Haussler M.R., St-Arnaud R. A composite element binding the vitamin D receptor, retinoid X receptor alpha, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter. Mol. Cell. Biol. 16:1996;584-592.
12. Chen J.D., Evans R.M. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature. 377:1995;454-457.
13. Chen H.W., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., Evans R.M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell. 90:1997;569-580.
14. Chen H., Lin R.J., Xie W., Wilpitz D., Evans R.M. Regulation of hormone-induced histone hyperacetylation and gene activation via acetylation of an acetylase. Cell. 98:1999;675-686.
15. 3. Biochem. J. 316:1996;361-371.
16. 3: a transcriptional modulator of the interferon-gamma gene. Eur. J. Immunol. 28:1998;3017-3030.
17. 3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 101:1998;252-262.
18. Danielian P.S., White R., Lees J.A., Parker M.G. Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J. 11:1992;1025-1033.
19. Darimont B.D., Wagner R.L., Apriletti J.W., Stallcup M.R., Kushner P.J., Baxter J.D., Fletterick R.J., Yamamoto K.R. Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev. 12:1998;3343-3356.
20. DeLuca H.F. New concepts of vitamin D functions. Ann. NY Acad. Sci. 669:1992;59-69.
21. Ding X.F., Anderson C.M., Ma H., Hong H., Uht R.M., Kushner P.J., Stallcup M.R. Nuclear receptor-binding sites of coactivators glucocorticoid receptor interacting protein 1 (GRIP1) and steroid receptor coactivator 1 (SRC-1): multiple motifs with different binding specificities. Mol. Endocrinol. 12:1998;302-313.
22. Durand B., Saunders M., Gaudon C., Roy B., Losson R., Chambon P. Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J. 13:1994;5370-5382.
23. Fondell J.D., Ge H., Roeder R.G. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl. Acad. Sci. USA. 93:1996;8329-8333.
24. Fondell J.D., Guermah M., Malik S., Roeder R.G. Thyroid hormone receptor-associated proteins and general positive cofactors mediate thyroid hormone receptor function in the absence of the TATA box-binding protein-associated factors of TFIID. Proc. Natl. Acad. Sci. USA. 96:1999;1959-1964.
25. Fraser R.A., Heard D.J., Adam S., Lavigne A.C., Le Douarin B., Tora L., Losson R., Rochette-Egly C., Chambon P. The putative cofactor TIF1alpha is a protein kinase that is hyperphosphorylated upon interaction with liganded nuclear receptors. J. Biol. Chem. 273:1998;16199-16204.
26. Freedman L.P. Molecular Biology of Steroid and Nuclar Hormone Receptors. 1998;Birkhauser, Boston, MA.
27. Freedman L.P. Increasing the complexity of coactivation in nuclear receptor signaling. Cell. 97:1999;5-8.
28. Ge H., Zhao Y., Chait B.T., Roeder R.G. Phosphorylation negatively regulates the function of coactivator PC4. Proc. Natl. Acad. Sci. USA. 91:1994;12691-12695.
29. Glass C.K. Differential recognition of target genes by nuclear receptor monomers, dimers and heterodimers. Endocr. Rev. 15:1994;391-407.
30. Goldman P.S., Tran V.K., Goodman R.H. The multifunctional role of the co-activator CBP in transcriptional regulation. Recent Prog. Horm. Res. 52:1997;103-119.
31. Gu B., Aslam F., van Wijnen A.J., Roberts S.G., Frenkel B., Green M.R., DeLuca H., Lian J.B., Stein G.S., Stein J.L. YY1 regulates vitamin D receptor/retinoid X receptor mediated transactivation of the vitamin D responsive osteocalcin gene. Proc. Natl. Acad. Sci. USA. 94:1997;121-126.
32. Gu W., Roeder R.G. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell. 90:1997;595-606.
33. Gu W., Malik S., Ito M., Yuan C.X., Fondell J.D., Zhang X., Martinez E., Qin J., Roeder R.G. A novel human SRB/MED-containing cofactor complex, SMCC, involved in transcription regulation. Mol. Cell. 3:1999;97-108.
34. Heery D.M., Kalkhoven E., Hoare S., Parker M.G. A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature. 387:1997;733-736.
35. Hengartner C.J., Myer V.E., Liao S.M., Wilson C.J., Koh S.S., Young R.A. Temporal regulation of RNA polymerase II by Srb10 and Kin28 cyclin-dependent kinases. Mol. Cell. 2:1998;43-53.
36. Henry N.L., Bushnell D.A., Kornberg R.D. A yeast transcriptional stimulatory protein similar to human PC4. J. Biol. Chem. 271:1996;21842-21847.
37. Herrlich P., Gottlicher M. Transcriptional cross talk by steroid hormone receptors. Freedman L.P. Molecular Biology of Steroid and Nuclear Hormone Receptors. 1998;191-208 Birkhauser, Boston, MA.
38. Hittelman A.B., Burakov D.J., Iniguez-Lluhi J.A., Freedman L.P., Garabedian M.J. Differential regulation of glucocorticoid receptor transcriptional activation via AF-1-associated proteins. EMBO J. 18:1999;5380-5388.
39. Hong H., Kohli K., Garabedian M.J., Stallcup M.R. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Mol. Cell. Biol. 17:1997;2735-2744.
40. Horlein A.J., Naar A.M., Heinzel T., Torchia J., Gloss B., Kurokawa R., Ryan A., Kamei Y., Soderstrom M., Glass C.K., et al. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature. 377:1995;397-404.
41. Imhof A., Yang X.J., Ogryzko V.V., Nakatani Y., Wolffe A.P., Ge H. Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. 7:1997;689-692.
42. Ito M., Yuan C.X., Malik S., Gu W., Fondell J.D., Yamamura S., Fu Z.Y., Zhang X., Qin J., Roeder R.G. Identity between TRAP and SMCC complexes indicates novel pathways for the function of nuclear receptors and diverse mammalian activators. Mol. Cell. 3:1999;361-370.
43. Jiang Y.W., Veschambre P., Erdjument-Bromage H., Tempst P., Conaway J.W., Conaway R.C., Kornberg R.D. Mammalian mediator of transcriptional regulation and its possible role as an end-point of signal transduction pathways. Proc. Natl. Acad. Sci. USA. 95:1998;8538-8543.
44. 3 receptor identifying C-terminal amino acids required for transcriptional activation that are functionally dissociated from hormone binding, heterodimeric DNA binding and interaction with basal transcription factor IIB, in vitro. J. Biol. Chem. 272:1997;14592-14599.
45. Kim Y.J., Bjorklund S., Li Y., Sayre M.H., Kornberg R.D. A multiprotein mediator of transcriptional activation and its interaction with the C-terminal repeat domain of RNA polymerase II. Cell. 77:1994;599-608.
46. Koleske A.J., Young R.A. An RNA polymerase II holoenzyme responsive to activators. Nature. 368:1994;466-469.
47. Koszewski N.J., Reinhardt T.A., Horst R.L. Vitamin D receptor interactions with the murine osteopontin response element. J. Steroid Biochem. Mol. Biol. 59:1996;377-388.
48. Kretzschmar M., Kaiser K., Lottspeich F., Meisterernst M. A novel mediator of class II gene transcription with homology to viral immediate-early transcriptional regulators. Cell. 78:1994;525-534.
49. Kretzschmar M., Stelzer G., Roeder R., Meisterernst M. RNA polymerase II cofactor PC2 facilitates activation of transcription by GAL4-AH in vitro. Mol. Cell. Biol. 14:1994;3927-3937.
50. Kurokawa R., Yu V., Naar A., Kyakumoto S., Han Z., Silverman S., Rosenfeld M.G., Glass C.K. Differential orientations of the DNA binding domain and C-terminal interface regulate binding site selection by nuclear receptor heterodimers. Genes Dev. 7:1993;1423-1435.
51. Lanz R.B., McKenna N.J., Onate S.A., Albrecht U., Wong J., Tsai S.Y., Tsai M.J., O'Malley B.W. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell. 97:1999;17-27.
52. Lavigne A.C., Mengus G., Gangloff Y.G., Wurtz J.M., Davidson I. Human TAF(II)55 interacts with the vitamin D(3) and thyroid hormone receptors and with derivatives of the retinoid X receptor that have altered transactivation properties. Mol. Cell. Biol. 19:1999;5486-5494.
53. Le Douarin B., vom Baur E., Zechel C., Heery D., Heine M., Vivat V., Gronemeyer H., Losson R., Chambon P. Ligand-dependent interaction of nuclear receptors with potential transcriptional intermediary factors (mediators). Phil. Trans. R. Soc. Lond. B. 351:1996;569-578.
54. Lee Y.C., Min S., Gim B.S., Kim Y.J. A transcriptional mediator protein that is required for activation of many RNA polymerase II promoters and is conserved from yeast to humans. Mol. Cell. Biol. 17:1997;4622-4632.
55. 3. J. Steroid Biochem. Mol. Biol. 53:1995;599-602.
56. 3-dependent cell-free transcription. Mol. Cell. Biol. 17:1997;1923-1937.
57. Lemon B.D., Freedman L.P. Nuclear receptor cofactors as chromatin remodelers. Curr. Opin. Genet. Dev. 9:1999;499-504.
58. Li Y., Bjorklund S., Jiang Y.W., Kim Y.J., Lane W.S., Stillman D.J., Kornberg R.D. Yeast global transcriptional regulators Sin4 and Rgr1 are components of mediator complex/RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. USA. 92:1995;10864-10868.
59. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev. 10:1996;142-153.
60. Liu Z., Wong J., Tsai S.Y., Tsai M.J., O'Malley B.W. Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin. Proc. Natl. Acad. Sci. USA. 96:1999;9485-9490.
61. Luisi B.F., Xu W., Otwinowski Z., Freedman L.P., Yamamoto K.R., Sigler P.B. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature. 352:1991;497-505.
62. MacDonald P., Sherman D., Dowd D., Jefcoat S.J., DeLisle R. The vitamin D receptor interacts with general transcription factor IIB. J. Biol. Chem. 270:1995;4748-4752.
63. McInerney E.M., Rose D.W., Flynn S.E., Westin S., Mullen T.M., Krones A., Inostroza J., Torchia J., Nolte R.T., Assa-Munt N., Milburn M.V., Glass C.K., Rosenfeld M.G. Determinants of coactivator LXXLL motif specificity in nuclear receptor transcriptional activation. Genes Dev. 12:1998;3357-3368.
64. McKenna N.J., Nawaz Z., Tsai S.Y., Tsai M.J., O'Malley B.W. Distinct steady-state nuclear receptor coregulator complexes exist in vivo. Proc. Natl. Acad. Sci. USA. 95:1998;11697-11702.
65. McKenna N.J., Xu J., Nawaz Z., Tsai S.Y., Tsai M.J., O'Malley B.W. Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J. Steroid Biochem. Mol. Biol. 69:1999;3-12.
66. McNeil S., Gu B., Stein J.L., Lian J.B., Bushmeyer S., Seto E., Atchison M.L., Penman S., van Wijnen A.J., Stein G.S. Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: the C-terminus is a principal determinant for nuclear trafficking. J. Cell. Biochem. 68:1998;500-510.
67. Mak H.Y., Hoare S., Henttu P.M., Parker M.G. Molecular determinants of the estrogen receptor-coactivator interface. Mol. Cell. Biol. 19:1999;3895-3903.
68. Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., Umesono K., Blumberg B., Kastner P., Mark M., Chambon P., Evans R.M. The nuclear receptor superfamily: the second decade. Cell. 83:1995;835-839.
69. Masuyama H., Brownfield C.M., StArnaud R., MacDonald P.N. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction. Mol. Endocrinol. 11:1997;1507-1517.
70. Masuyama H., Jefcoat S.C. Jr., MacDonald P.N. The N-terminal domain of transcription factor IIB is required for direct interaction with the vitamin D receptor and participates in vitamin D-mediated transcription. Mol. Endocrinol. 11:1997;218-228.
71. May M., Mengus G., Lavigne A.C., Chambon P., Davidson I. Human TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptors. EMBO J. 15:1996;3093-3104.
72. 3, and thyroid hormone receptors in mammalian cells. Genes Dev. 11:1997;1381-1395.
73. Myer V.E., Young R.A. RNA polymerase II holoenzymes and subcomplexes. J. Biol. Chem. 273:1998;27757-27760.
74. Myers L.C., Gustafsson C.M., Bushnell D.A., Lui M., Erdjument-Bromage H., Tempst P., Kornberg R.D. The Med proteins of yeast and their function through the RNA polymerase II carboxy-terminal domain. Genes Dev. 12:1998;45-54.
75. Myers L.C., Gustafsson C.M., Hayashibara K.C., Brown P.O., Kornberg R.D. Mediator protein mutations that selectively abolish activated transcription. Proc. Natl. Acad. Sci. USA. 96:1999;67-72.
76. Naar A.M., Beaurang P.A., Robinson K.M., Oliner J.D., Avizonis D., Scheek S., Zwicker J., Kadonaga J.T., Tjian R. Chromatin, TAFs, and a novel multiprotein coactivator are required for synergistic activation by Sp1 and SREBP-1a in vitro. Genes Dev. 12:1998;3020-3031.
77. Naar A.M., Beaurang P.A., Zhou S., Abraham S., Solomon W., Tjian R. Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature. 398:1999;828-832.
78. Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R., Rosenfeld M.G., Willson T.M., Glass C.K., Milburn M.V. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma. Nature. 395:1998;137-143.
79. Norman A.W., Adams D., Collins E.D., Okamura W.H., Fletterick R.J. Three-dimensional model of the ligand binding domain of the nuclear receptor for 1alpha,25-dihydroxy-vitamin D(3). J. Cell. Biochem. 74:1999;323-333.
80. Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell. 87:1996;953-959.
81. Onate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. Sequence and characterization of a co-activator for the steroid hormone receptor superfamily. Science. 270:1995;1354-1357.
82. Parvin J.D., Young R.A. Regulatory targets in the RNA polymerase II holoenzyme. Curr. Opin. Genet. Dev. 8:1998;565-570.
83. Perlmann T., Rangarajan P.N., Umesono K., Evans R.M. Determinants for selective RAR and TR recognition of direct repeat HREs. Genes Dev. 7:1993;1411-1422.
84. Pike A.C., Brzozowski A.M., Hubbard R.E., Bonn T., Thorsell A.G., Engstrom O., Ljunggren J., Gustafsson J.A., Carlquist M. Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J. 18:1999;4608-4618.
85. 3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev. 12:1998;1787-1800.
86. Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M., Naar A.M., Erdjument-Bromage H., Tempst P., Freedman L.P. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature. 398:1999;824-828.
87. Rastinejad F., Perlmann T., Evans R.M., Sigler P.B. Structural determinants of nuclear receptor assembly on DNA direct repeats. Nature. 375:1995;203-211.
88. Renaud J., Rochel N., Ruff M., Vivat V., Chambon P., Gronemeyer H., Moras D. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature. 378:1995;681-689.
89. Rigby W.F. The immunobiology of vitamin D. Immunol. Today. 9:1988;54-58.
90. Roeder R.G. The role of general initiation factors in transcription by RNA polymerase II. Trends Biochem. Sci. 21:1996;327-335.
91. 3 induction in myeloid leukemic cells. Mol. Cell. Biol. 18:1998;1911-1918.
92. Ryu S., Zhou S., Ladurner A.G., Tjian R. The transcriptional cofactor complex CRSP is required for activity of the enhancer-binding protein Sp1. Nature. 397:1999;446-450.
93. Schwabe J.W.R., Chapman L., Finch J.T., Rhodes D. The crystal structure of the oestrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell. 75:1993;567-578.
94. Spencer T.E., Jenster G., Burcin M.M., Allis C.D., Zhou J.X., Mizzen C.A., McKenna N.J., Onate S.A., Tsai S.Y., Tsai M.J., O'Malley B.W. Steroid receptor coactivator-1 is a histone acetyltransferase. Nature. 389:1997;194-198.
95. Sun X., Zhang Y., Cho H., Rickert P., Lees E., Lane W., Reinberg D. NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription. Mol. Cell. 2:1998;213-222.
96. Thompson C.M., Young R.A. General requirement for RNA polymerase II holoenzymes in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;4587-4590.
97. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature. 387:1997;677-684.
98. Torchia J., Glass C., Rosenfeld M.G. Co-activators and co-repressors in the integration of transcriptional responses. Curr. Opin. Cell. Biol. 10:1998;373-383.
99. 3 receptor: mechanism of dimer binding to an asymmetric repeat element. Proc. Natl. Acad. Sci. USA. 90:1993;6310-6314.
100. 3-mediated transcriptional repression of the granulocyte-macrophage colony-stimulating factor gene: vitamin D receptor competes for DNA binding with NFAT1 and stabilizes c-Jun. Mol. Cell. Biol. 19:1999;4191-4199.
101. Treuter E., Johansson L., Thomsen J.S., Warnmark A., Leers J., Pelto-Huikko M., Sjöberg M., Wright A.P., Spyrou G., Gustafsson J. Competition between Thyroid Hormone Receptor-associated Protein (TRAP) 220 and Transcriptional Intermediary Factor (TIF) 2 for Binding to Nuclear Receptors. Implications for the recruitment of trap and p160 coactivator complexes. J. Biol. Chem. 274:1999;6667-6677.
102. Tudor M., Murray P.J., Onufryk C., Jaenisch R., Young R.A. Ubiquitous expression and embryonic requirement for RNA polymerase II coactivator subunit srb7 in mice. Genes Dev. 13:1999;2365-2368.
103. Umesono K., Evans R.M. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell. 57:1989;1139-1146.
104. 3 receptors. Cell. 65:1991;1255-1266.
105. Voegel J.J., Heine M.J., Tini M., Vivat V., Chambon P., Gronemeyer H. The coactivator TIF2 contains three nuclear receptor-binding motifs and mediates transactivation through CBP binding-dependent and -independent pathways. EMBO J. 17:1998;507-519.
106. Wagner R.L., Apriletti J.W., McGrath M.E., West B.L., Baxter J.D., Fletterick R.J. A structural role for hormone in the thyroid hormone receptor. Nature. 378:1995;690-697.
107. Williams S.P., Sigler P.B. Atomic structure of progesterone complexed with its receptor. Nature. 393:1998;392-396.
108. Xu J., Qiu Y., DeMayo F.J., Tsai S.Y., Tsai M.J., O'Malley B.W. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science. 279:1998;1922-1925.
109. Xu L., Glass C.K., Rosenfeld M.G. Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev. 9:1999;140-147.
110. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., Kawakami T., Arioka K., Sato H., Uchiyama Y., Masushige S., Fukamizu A., Matsumoto T., Kato S. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 16:1997;391-396.
111. Zawel L., Reinberg D. Common themes in assembly and function of eukaryotic transcription complexes. Annu. Rev. Biochem. 64:1995;533-561.